Analyst Expectations For Silence Therapeutics’s Future – Silence Therapeutics (NASDAQ:SLN)
All through the final three months, 7 analysts have evaluated Silence Therapeutics SLN, providing a various set of opinions from bullish to bearish. The desk under offers a concise overview of latest rankings by analysts, providing insights into the altering sentiments over the previous 30 days and drawing comparisons with the previous months for a […]









